Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Radiation Injuries 1Head and Neck Neoplasms 1Depression 1

Interventions

Radiotherapy 8Cisplatin 3Carboplatin 3sargramostim 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Donepezil 2cevimeline 1beta Carotene 1alpha-Tocopherol 1Zinc Sulfate 1Vortioxetine 1Vitamin E 1Standard of Care 1Sodium Chloride 1Salts 1Radiotherapy, Conformal 1Radiosurgery 1Oxygen 1Oxaliplatin 1Neck Dissection 1Mometasone Furoate 1Meditation 1Hyperbaric Oxygenation 1Glutamine 1G(M1) Ganglioside 1Filgrastim 1Fibroblast Growth Factor 7 1Etoposide 1Erythropoietin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Radiation Injuries × Vortioxetine × Clear all
NCT04818099 2021-03-26

Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 3 Unknown
208 enrolled
Head & Neck

Depression, Head and Neck Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡